Featured Topics
Learn more about 2026 ISPE Pharma 4.0™ and Biopharma Conference Tracks
The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions showcase recent innovations and trends and directly discuss practical challenges and solutions from a technical, logistical, and regulatory perspective. Our education program offers cutting-edge technical sessions shedding light on the latest advancements in areas like supply chain operations, facilities design and maintenance, and regulatory affairs, with a focus on how Pharma 4.0 is driving the next generation of product development, production systems, and quality assurance.
Pharma 4.0 Enabling Digital Foundations
Digital transformation depends on more than individual technologies. This track focuses on the building blocks required to make Pharma 4.0™ successful. Topics include data readiness, interoperability, digital architecture, governance, and enabling technologies. Sessions will explore how these capabilities improve transparency, decision-making, and operational resilience. Attendees will learn how strong digital foundations can support innovation across pharmaceutical manufacturing.
Pharma 4.0™ Compliant by Design
This track explores how Pharma 4.0™ principles translate into the next generation of regulatory-compliant, digitally enabled quality systems. Sessions span the full compliance arc — from trusted data infrastructure and AI-driven quality operations to real-world inspector expectations in an era of electronic evidence. Industry leaders and regulatory voices examine what it takes to move from digital transformation intent to inspection-ready operations, covering emerging requirements for ATMPs, AI in GxP, and beyond.
Pharma 4.0™ in Action: Biopharma Manufacturing Transformation
Where the "Pharma 4.0™ Enabling Digital Foundations" builds the digital foundations and "Pharma 4.0™ Compliant by Design" addresses regulatory trust, this track integrates Pharma 4.0™ in action. Sessions span the biopharmaceutical manufacturing lifecycle: traditional biologics, plasma fractionation, ATMPs, cell and gene therapies, and aseptic fill-finish through case studies and lessons learned from real-world implementations. Industry leaders and subject matter experts examine how trusted data ecosystems, advanced analytics, artificial intelligence (AI), and integrated robotic platforms improve process performance, enhance decision-making, and strengthen deviation management. Emphasis will be placed on real-world implementation strategies that augment human expertise rather than replace it. Attendees will gain valuable insights into how leading organizations are responsibly deploying AI to advance manufacturing excellence while upholding the highest standards of quality, compliance, transparency, and accountability.